Gene · 51684
SUFU: SUFU negative regulator of hedgehog signaling
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SUFU: SUFU negative regulator of hedgehog signaling. Genes, record 51684. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51684
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UMX1 | Suppressor of fused homolog | 484 | 10 | Ensembl, GeneID, HGNC |
Source UniProt
Patents37
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 8689 | Q9UMX1 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8689 | Q9UMX1 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8585 | Q9UMX1 | Espacenet |
| WO 2023022218 A | 2023-02-23 | 28 | Q9UMX1 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 85135 | Q9UMX1 | Espacenet |
| JP 2022537339 A | 2022-08-25 | 128 | Q9UMX1 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 188106 | Q9UMX1 | Espacenet |
| US 10501513 B2 | 2019-12-10 | 8585 | Q9UMX1 | Espacenet |
| US 10330683 B2 | 2019-06-25 | 10 | Q9UMX1 | Espacenet |
| JP 2019509721 A | 2019-04-11 | 5 | Q9UMX1 | Espacenet |
1 to 10 of 37
See all 37 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,282
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SUFU papers | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 17 | 2025 |
| R01CA159859 | Dysregulation of the Core Binding Factor Complex Inhibits Differentiation and Drives Group 4 Medulloblastoma | 17 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 15 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 15 | 2025 |
| P01CA096832 | NORMAL & NEOPLASTIC GROWTH IN THE BRAIN | 13 | 2025 |
| R35GM118063 | Cell signaling in development and regeneration | 10 | 2025 |
| R01AR046786 | Stromal Regulation of Basal Cell Carcinoma Formation | 9 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 8 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 7 | 2025 |
| R35GM118082 | Signal transduction in development and disease | 5 | 2025 |
1 to 10 of 1,282Source NIH's project files
See all 1,282 nih grantsPapers2,311
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular profiling of pediatric medulloblastoma in Kazakhstan: Genomic alterations, subgroup distribution, and survival. | Brain Pathol | 2026 | 42707049 | PubTator, text mining | PubMed |
| Population-based genomic detection of childhood cancer predisposition using newborn dried blood spots. | Nat Commun | 2026 | 42586985 | PubTator, text mining | PubMed |
| Delayed Recognition of SUFU-Associated Gorlin Syndrome in a Renal Transplant Recipient. | Dermatol Surg | 2026 | 42574229 | PubTator, text mining | PubMed |
| PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients. | Klin Padiatr | 2026 | 42462758 | PubTator, text mining | PubMed |
| Mechanistic insights into transcriptional regulation of ARHGAP36 expression identify a factor predictive of neuroblastoma survival. | Elife | 2026 | 42405753 | PubTator, text mining | PubMed |
| Gorlin Syndrome: A Series of 10 Patients. Diagnosis, Follow-up, and Treatment from the Dermatological Consultation. | Clin Exp Dermatol | 2026 | 42323190 | PubTator, text mining | PubMed |
| JOSD1-mediated stabilization of SUFU controls pancreatic cancer progression. | Cell Death Dis | 2026 | 42248831 | PubTator, text mining | PubMed |
| Proteome-wide serology reveals immune-defined subtypes of gastrointestinal disease in systemic sclerosis. | bioRxiv | 2026 | 42239272 | PubTator, text mining | PubMed |
| Germline Predisposition in Pediatric Central Nervous System Tumors: Insights from a Multigene Panel Study. | Oncol Res | 2026 | 42232602 | PubTator, text mining | PubMed |
| Multi-Layered Genomic and Clinical Analysis Identifies Novel Variants, Co-Occurring Single Nucleotide Polymorphism Pairs, and Clinical Determinants of Host-Pathogen Interaction in COVID-19 Severity. | J Med Virol | 2026 | 42198887 | PubTator, text mining | PubMed |
1 to 10 of 2,311
See all 2,311 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51684
GET https://conductscience.org/api/genes/v1/51684/patents?page=2